Human NRF2 PharmaGenie ELISA Kit (SBRS0941)

NRF2 (NFE2L2) sits at the center of the cellular antioxidant defense system, coordinating expression of phase II detoxifying enzymes and cytoprotective proteins such as NQO1, HMOX1, and glutamate-cysteine ligase. The Assay Genie Human NRF2 PharmaGenie ELISA Kit enables quantitative measurement of this transcription factor in cell culture supernatants, plasma, and serum through a colorimetric immunoassay workflow compatible with standard microplate readers. Researchers studying oxidative stress, xenobiotic metabolism, chemoprevention, and inflammatory signaling rely on NRF2 quantification to evaluate pathway activation across oncology, neurodegeneration, and chronic inflammation models. The 96-assay configuration supports mid-throughput studies bridging in vitro mechanistic work with clinical sample analysis. Each kit includes pre-coated plates, detection antibodies, and calibrated standards specific to human NRF2, with protocols structured for research use only in academic, pharmaceutical, and biotechnology laboratories.